Eliminate risks associated with open-heart surgeries
AquaBlade, a new medical device invented at the University of Nebraska Medical Center, could provide a less invasive treatment for cardiovascular disease and eliminate a significant amount of the inherent risks associated with open-heart surgeries.
AquaBlade is an innovative surgical instrument that uses a catheter to deliver a specialized cutting tool through a patient’s artery where it uses a high-pressure water jet to repair life-threatening tears in artery walls. The device could also be used to deploy custom-length stents in blood vessels or even help remove previously deployed stents.
Arterial tears in the inner lining of an artery causes the formation of blood clots that obstruct blood flow and eventually lead to a heart attack or stroke. If left untreated, an arterial tear is fatal for 80 percent of patients. Current treatments for arterial tears often require open-heart surgery, which carries a 25 percent risk of death and an extended recovery period.
AquaBlade eliminates most of those risks while also minimizing the time of recovery. It is currently at the conceptual stage, preparing a functional prototype for preclinical testing.
To discuss licensing opportunities please contact Matt Boehm, Ph.D., at firstname.lastname@example.org or 402-559-2166.